By choosing this Impact Area, you are supporting companies which improve quality and access of healthcare. You are steering away from companies limiting access to quality healthcare or producting and distributing harmful products and substances. Think COVID-19 vaccines and medications.
Why It Matters
- The world is currently experiencing a pandemic of an infectious disease called coronavirus disease 2019 or COVID-19.
- Immunization prevents 2-3 million deaths a year and an additional 1.5 million deaths could be avoided if global vaccination coverage improves.
- Death rates have been rising over the past 10 years for young and middle-aged adults, driving down overall life expectancy in the United States for 3 consecutive years.
- Heart disease is the leading cause of death for men, women, and people of most racial and ethnic groups in the United States. One person dies every 37 seconds in the United States from cardiovascular disease.
We evaluate companies based on how they are:
✔ Researching, developing and improving access to life changing medical devices, medications and vaccines
✔ Advancing technology improving diagnoses and patient treatment
✔ Producing and distributing products detrimental to health e.g., cigarettes, firearms or other toxic substances
Diplomat Pharmacy, Inc.
Owens & Minor, Inc.
specialized healthcare supplies and drug application aids
Mallinckrodt Public Limited Company
prescription pharmaceuticals, active pharmaceutical ingredients, over-the-counter pharmaceuticals
Tenet Healthcare Corp.
hospitals, surgery centres, diagnostic imaging centers
Recap is a sustainable investing platform that enables you to easily and transparently invest only in the companies that share the same environmental and social vision as you.
Recap's performance is hypothetical and does not represent the investment performance or the actual accounts of any clients. The securities in the hypothetical portfolio were selected with the full benefit of hindsight, after their performance over the period shown was known. The results achieved in our simulations do not guarantee future investment results. The model performance information is based on the back-tested performance of hypothetical investments over the time periods indicated. “Back-testing” is a process of objectively simulating historical investment returns by applying a set of rules for buying and selling securities, and other assets, backward in time, testing those rules, and hypothetically investing in the securities and other assets that are chosen. Any comparisons to indices are provided for illustrative purposes only.